• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » John Brosky

Articles by John Brosky

Edwards faces new game as Medtronic enters valve arena

July 1, 2009
By John Brosky

Expanding effort: Studies, new products broaden applications of interventional techniques in cardiology

July 1, 2009
By John Brosky
BARCELONA, Spain – The annual congress for cardiac interventionalists in Europe, EuroPCR has traditionally been focused on balloon angioplasty and stenting of coronary arteries, an emphasis reflected in the original name of the event, the Paris Course on Revascularization (PCR). (Cardiovascular Devices & Drugs)
Read More

Report from Europe: U.S.-style CEOs to run French hospitals under new reform law

June 30, 2009
By John Brosky

Report from Europe: Swiss HQ supports explosive growth in Europe for Edwards

June 29, 2009
By John Brosky

Low-tech box trainers adapt quickly to high-tech endoscopy

June 29, 2009
By John Brosky

Endoscopic surgery's safety record alarms Dutch ministry

June 26, 2009
By John Brosky

Olympus, Storz push product lines for scar-free surgery

June 25, 2009
By John Brosky

NOTES seen faltering as single-port access advances

June 24, 2009
By John Brosky

Higher hurdles: health reform means hard performance data

June 10, 2009
By John Brosky
DÜSSELDORF, Germany – The greater scrutiny of medical devices that is inherent in the coming reform of healthcare payment systems in both the U.S. and Europe is changing the game for the development of medical devices, putting a heavier burden on startups to prove performance against health economics models, and it will also have deep impact on how, and to whom, devices are sold. (Medical Device Daily)
Read More

No exit: Med-techs find fewer, more selective buyers for firms

June 9, 2009
By John Brosky
DÜSSELDORF, Germany — Since no one can talk any longer about the possibility of an initial public offering (IPO) for a medical device company, calling it the "imaginary public offering" got a nervous laugh from the medical technology executives gathered with 40 venture capital firms here last week for a pure-partnering event, EuroMedtech 2009. (Medical Device Daily)
Read More
Previous 1 2 … 61 62 63 64 65 66 67 68 69 … 101 102 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 8, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • Kidney disease illustration

    Prokidney produces positive phase II CKD data, thunderous stock surge

    BioWorld
    A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe